Feb 1, 2020 - In June 2019, the Advisory Committee on Immunization Practices approved a change from its age-based 13-valent pneumococcal conjugate vaccine recommendations to a shared clinical decision-making process.
American Family Physician : Editorials
Apr 1, 2018 - Pneumococcal vaccines had no significant effect on mortality from cardiorespiratory disease when compared with control and had no significant effect on all-cause mortality. Find out more.
American Family Physician : Medicine by the Numbers
May 1, 2018 - The 23-valent pneumococcal polysaccharide vaccine (PPSV23; Pneumovax 23) decreases the relative risk of community-acquired pneumonia in adults by 13%. The risk is reduced by 28% in the population that includes adults older than 65 years, those with lung disease, and those living in a ...
American Family Physician : FPIN's Help Desk Answers
Jul 15, 2011 - What are the effects of interventions to prevent community-acquired pneumonia? What are the effects of treatments for community-acquired pneumonia in outpatient settings and in persons admitted to a hospital or receiving instensive care?
American Family Physician : Clinical Evidence Handbook
Aug 1, 2004 - Recommendations on reducing the incidence of pneumonia and other severe, acute lower respiratory tract infections in acute-care hospitals and in other health care settings have been released by the Centers for Disease Control and Prevention (CDC) and the Healthcare Infection Control ...
American Family Physician : Practice Guidelines
navigate_before 1 navigate_next